drugset / Trial / NCT00858195

A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules

NCT00858195

Phase 1 Completed 36 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the bioequivalence of Indomethacin ER Capsules.

Timeline

Start
2006-06
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Indomethacin Small molecule 75 mg

Indications

No indication recorded.